Identifier |
Protein names |
Gene names |
Cross reference refseq |
Length |
Species |
Q658X4
|
Putative uncharacterized protein DKFZp666G0810; Fragment;
|
DKFZp666G0810;
|
NULL
|
405
|
human
|
Q67AC4
|
MHC class II antigen; Fragment;
|
HLA-DQA1;
|
NULL
|
27
|
human
|
Q68DI5
|
Putative uncharacterized protein DKFZp781H1425;
|
DKFZp781H1425;
|
NULL
|
983
|
human
|
Q68D89
|
Putative uncharacterized protein DKFZp686D10126; Fragment;
|
DKFZp686D10126;
|
NULL
|
128
|
human
|
Q2PRN6
|
Mutant ATP-binding cassette sub-family D member 1; Fragment;
|
ABCD1;
|
NULL
|
48
|
human
|
Q6FG54
|
ETS1 protein;
|
ETS1;
|
NULL
|
441
|
human
|
Q59GY9
|
Multidrug resistance protein 1 variant; Fragment;
|
NULL
|
NULL
|
1062
|
human
|
Q6FHH0
|
CCNI protein; Fragment;
|
CCNI;
|
NULL
|
377
|
human
|
Q5U0D0
|
Mitogen-activated protein kinase kinase kinase 7;
|
NULL
|
NULL
|
579
|
human
|
Q5HYD8
|
Putative uncharacterized protein DKFZp686M0919;
|
DKFZp686M0919;
|
NULL
|
533
|
human
|
Q59EH2
|
Amyloid beta protein-binding, family B, member 3 isoform b variant; Fragment;
|
NULL
|
NP_006042.3;NP_573418.2;NP_573419.2;NP_573420.2;
|
515
|
human
|
Q5W1J8
|
MHC class I antigen; Fragment;
|
HLA-B;
|
NULL
|
181
|
human
|
Q6H2H1
|
Natural killer cell inhibitory receptor;
|
KIR2DL1;
|
NULL
|
348
|
human
|
Q6P5X6
|
ANKRD13B protein; Fragment;
|
ANKRD13B;
|
NULL
|
613
|
human
|
Q6NSD0
|
SLCO1B3 protein; Fragment;
|
SLCO1B3;
|
NULL
|
296
|
human
|
Q6UWP5
|
HHSL751;
|
NULL
|
NULL
|
143
|
human
|
Q6FHU0
|
Proteasome subunit beta type; EC 3.4.25.1; Fragment;
|
PSMB8;
|
NULL
|
272
|
human
|
Q68E09
|
Putative uncharacterized protein DKFZp686N1969;
|
DKFZp686N1969;
|
NULL
|
1487
|
human
|
Q4GK64
|
ATP synthase subunit a;
|
ATPase; 6;
|
NULL
|
226
|
human
|
Q8NDD3
|
Putative uncharacterized protein DKFZp586M1819; Fragment;
|
DKFZp586M1819;
|
NULL
|
264
|
human
|